The findings revealed substantially reduced mRNA levels of m6A, METTL3, METTL14, and YTH N6‐methyladenosine RNA binding protein F2 (YTHDF2) in PD patients compared to controls, with METTL14 identified as the primary cause. This evidence concerns the gene YTHDF2 and Parkinson disease.